424 related articles for article (PubMed ID: 24182851)
1. Monogenic autoinflammatory diseases: disorders of amplified danger sensing and cytokine dysregulation.
Sanchez GA; de Jesus AA; Goldbach-Mansky R
Rheum Dis Clin North Am; 2013 Nov; 39(4):701-34. PubMed ID: 24182851
[TBL] [Abstract][Full Text] [Related]
2. Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1.
Goldbach-Mansky R
Clin Exp Immunol; 2012 Mar; 167(3):391-404. PubMed ID: 22288582
[TBL] [Abstract][Full Text] [Related]
3. IL-1 blockade in autoinflammatory syndromes.
Jesus AA; Goldbach-Mansky R
Annu Rev Med; 2014; 65():223-44. PubMed ID: 24422572
[TBL] [Abstract][Full Text] [Related]
4. Monogenic autoinflammatory diseases: concept and clinical manifestations.
Almeida de Jesus A; Goldbach-Mansky R
Clin Immunol; 2013 Jun; 147(3):155-74. PubMed ID: 23711932
[TBL] [Abstract][Full Text] [Related]
5. The pathogenesis of neonatal autoimmune and autoinflammatory diseases: a comprehensive review.
Chang C
J Autoimmun; 2013 Mar; 41():100-10. PubMed ID: 23375846
[TBL] [Abstract][Full Text] [Related]
6. Autoinflammatory syndromes and cellular responses to stress: pathophysiology, diagnosis and new treatment perspectives.
Savic S; Dickie LJ; Wittmann M; McDermott MF
Best Pract Res Clin Rheumatol; 2012 Aug; 26(4):505-33. PubMed ID: 23040364
[TBL] [Abstract][Full Text] [Related]
7. The Relationship between NALP3 and Autoinflammatory Syndromes.
Campbell L; Raheem I; Malemud CJ; Askari AD
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187378
[TBL] [Abstract][Full Text] [Related]
8. Immunology in clinic review series; focus on autoinflammatory diseases: role of inflammasomes in autoinflammatory syndromes.
Ozkurede VU; Franchi L
Clin Exp Immunol; 2012 Mar; 167(3):382-90. PubMed ID: 22288581
[TBL] [Abstract][Full Text] [Related]
9. [Autoinflammatory syndromes in childhood].
Horneff G
Z Rheumatol; 2015 Aug; 74(6):511-24; quiz 525. PubMed ID: 26238708
[TBL] [Abstract][Full Text] [Related]
10. A dermatologic perspective on autoinflammatory diseases.
Marzano AV; Damiani G; Genovese G; Gattorno M
Clin Exp Rheumatol; 2018; 36 Suppl 110(1):32-38. PubMed ID: 29742056
[TBL] [Abstract][Full Text] [Related]
11. [Inflammasome and interleukin 1].
Jéru I; Amselem S
Rev Med Interne; 2011 Apr; 32(4):218-24. PubMed ID: 20541850
[TBL] [Abstract][Full Text] [Related]
12. [Genetics of cryopyrin-associated periodic syndrome].
Kümmerle-Deschner JB; Lohse P
Z Rheumatol; 2017 May; 76(4):313-321. PubMed ID: 28197772
[TBL] [Abstract][Full Text] [Related]
13. Genomics, Biology, and Human Illness: Advances in the Monogenic Autoinflammatory Diseases.
Oda H; Kastner DL
Rheum Dis Clin North Am; 2017 Aug; 43(3):327-345. PubMed ID: 28711137
[TBL] [Abstract][Full Text] [Related]
14. Monogenic autoinflammatory diseases: new insights into clinical aspects and pathogenesis.
Henderson C; Goldbach-Mansky R
Curr Opin Rheumatol; 2010 Sep; 22(5):567-78. PubMed ID: 20671522
[TBL] [Abstract][Full Text] [Related]
15. Additive loss-of-function proteasome subunit mutations in CANDLE/PRAAS patients promote type I IFN production.
Brehm A; Liu Y; Sheikh A; Marrero B; Omoyinmi E; Zhou Q; Montealegre G; Biancotto A; Reinhardt A; Almeida de Jesus A; Pelletier M; Tsai WL; Remmers EF; Kardava L; Hill S; Kim H; Lachmann HJ; Megarbane A; Chae JJ; Brady J; Castillo RD; Brown D; Casano AV; Gao L; Chapelle D; Huang Y; Stone D; Chen Y; Sotzny F; Lee CC; Kastner DL; Torrelo A; Zlotogorski A; Moir S; Gadina M; McCoy P; Wesley R; Rother KI; Hildebrand PW; Brogan P; Krüger E; Aksentijevich I; Goldbach-Mansky R
J Clin Invest; 2015 Nov; 125(11):4196-211. PubMed ID: 26524591
[TBL] [Abstract][Full Text] [Related]
16. C3 glomerulopathy in NLRP12-related autoinflammatory disorder: case-based review.
Başaran Ö; Uncu N; Çakar N; Turanlı ET; Kiremitci S; Aydın F; Bayrakcı US
Rheumatol Int; 2018 Aug; 38(8):1571-1576. PubMed ID: 29951964
[TBL] [Abstract][Full Text] [Related]
17. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases.
Aksentijevich I; Nowak M; Mallah M; Chae JJ; Watford WT; Hofmann SR; Stein L; Russo R; Goldsmith D; Dent P; Rosenberg HF; Austin F; Remmers EF; Balow JE; Rosenzweig S; Komarow H; Shoham NG; Wood G; Jones J; Mangra N; Carrero H; Adams BS; Moore TL; Schikler K; Hoffman H; Lovell DJ; Lipnick R; Barron K; O'Shea JJ; Kastner DL; Goldbach-Mansky R
Arthritis Rheum; 2002 Dec; 46(12):3340-8. PubMed ID: 12483741
[TBL] [Abstract][Full Text] [Related]
18. Current status of understanding the pathogenesis and management of patients with NOMID/CINCA.
Goldbach-Mansky R
Curr Rheumatol Rep; 2011 Apr; 13(2):123-31. PubMed ID: 21538043
[TBL] [Abstract][Full Text] [Related]
19. The classification, genetic diagnosis and modelling of monogenic autoinflammatory disorders.
Moghaddas F; Masters SL
Clin Sci (Lond); 2018 Sep; 132(17):1901-1924. PubMed ID: 30185613
[TBL] [Abstract][Full Text] [Related]
20. Monogenic autoinflammatory syndromes at a dermatological level.
Rigante D; Cantarini L
Arch Dermatol Res; 2011 Aug; 303(6):375-80. PubMed ID: 21340744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
